Back to search

Spain· ES:1171209021

REAGILA 4,5 MG CAPSULAS DURAS

A medicinal product containing cariprazina, registered in Spain by Gedeon Richter Plc..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedREAGILA 4,5 MG CAPSULAS DURASATC—REGISTER NO.ES:1171209021PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
cariprazina
Manufacturer
Gedeon Richter Plc.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    720209
    28
    EUR 65.13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cariprazina in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cariprazina products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Reagila
  • Liechtenstein · Reagila
  • Norway · Reagila

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b08b438b-ac65-4ea2-a825-6fc4490f7ff5
GET /v1/drugs/b08b438b-ac65-4ea2-a825-6fc4490f7ff5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1518452805000}",
  "nregistro": "1171209021",
  "substance": "cariprazina"
}

See everything about cariprazina.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.